Popular Articles

PROSTVAC(TM) Data Presented At The ASCO Meeting Demonstrates The Potential For Significant Increases In Life Expectancy In Late-Stage Prostate Cancer
Detailed data from a randomized Phase 2 study with PROSTVAC(TM) were presented Saturday at the ASCO Annual Meeting in Orlando. The presentation was made by Philip Kantoff MD, Professor of Medicine, Harvard Medical School, and the Dana-Farber Cancer Institute who is also the principal investigator of the study.
pharmacy online
Joint Replacement Patients With Diabetes Greatly Benefit From Controlled Glucose
Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions. According to a new study published in the July 2009 issue of The Journal of Bone and Joint Surgery (JBJS), those complications are less likely to occur when a diabetic patient has glucose levels under control.
News of the day
Inventors Develop Novel Technique To Help Customize, Enhance The Effectiveness Of Bladder Cancer Treatment
Researchers in the University of Virginia Department of Urology have developed a novel method that could help physicians determine the best course of treatment for patients suffering from bladder cancer.
Medical Devices

European Society Of Cardiology Congress 2009: 29 August To 2 September, 2009

The latest news on procedures, drugs and equipment in the field of cardiology will be presented at the European Society of Cardiology congress which will take place in Barcelona, from 29 August to 2 September. With over 30,000 participants, the ESC Congress is the world"s biggest cardiology meeting. A record number of abstract submissions - 9,848 - were registered this year, reflecting how the meeting is now the main platform for cardiovascular research. A growing number of abstracts came from outside Europe, reflecting the truly international dimension of the meeting. "Because cardiovascular disease is the main cause of mortality and morbidity and in recognition of the major advances that have been made in this field we felt that prevention and risk factor identification represented a really important theme to highlight" explains Prof Fausto Pinto, chairperson of the Congress Programme Committee. "Entitled "Prevention of Cardiovascular Disease from cell to man to society", our highlight offers the opportunity for doctors, scientists and governments to come together to discuss ways of decreasing the burden of cardiovascular disease on society." New joint sessions with sister societies, such as the European Society of Medical Oncology, looking at issues such as the cardiovascular effects of oncology drugs, and a new joint session with the European Commission that will explore the issues around how the European Commission supports cardiovascular research are on the programme this year. The ESC Congress is a unique forum bringing together all the different disciplines and players involved in cardiology, including doctors, basic scientists, epidemiologists, nurses, technicians and key opinion leaders. It covers both specific issues in the different disciplines as well as broader issues affecting all fields of cardiology. The European Society of Cardiology (ESC) represents 59,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe. ESC Press Office European Society of Cardiology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):